MS, H., DO, C., MS, D., AH, K., FM, R., RL, A., . . . JS, L. (2024). Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy. Ophthalmology, 131(6), 682. https://doi.org/10.1016/j.ophtha.2023.12.028
Chicago Style (17th ed.) CitationMS, Humayun, et al. "Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy." Ophthalmology 131, no. 6 (2024): 682. https://doi.org/10.1016/j.ophtha.2023.12.028.
MLA (9th ed.) CitationMS, Humayun, et al. "Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy." Ophthalmology, vol. 131, no. 6, 2024, p. 682, https://doi.org/10.1016/j.ophtha.2023.12.028.